Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,090.00    -10.00 (-0.91%)
Bid:
1,080.00
Ask:
1,100.00
Spread: 20.00 (1.852%)
Market Cap: £321.99m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Half Year Trading Update

19 Apr 2021 07:00

RNS Number : 7863V
Cerillion PLC
19 April 2021
Β 

19 April 2021

AIM: CER

Β Cerillion plc

("Cerillion" or "the Company")

Β 

Half Year Trading Update

Β 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2021.

Β 

Cerillion has experienced its strongest ever six-month trading period, exceeding management expectations. Revenue for the first half ended 31 March 2021 is expected to total approximately Β£12.8m, a 25% increase on the same period last year (H1 2020: Β£10.2m) and adjusted EBITDA is expected to be approximately Β£4.8m, a 77% rise on the comparative period last year (H1 2020: Β£2.7m). The Company's balance sheet remains strong, with net cash at 31 March 2021 up by 60% to approximately Β£7.7m (31 March 2020: Β£4.8m).

Β 

This excellent performance reflects three major factors; on-going work on new customer implementation projects, strong demand from existing customers, and two major contract wins totalling Β£18.4m, which were secured in March 2021.

Β 

Reflecting the strong momentum in the business, the Company has added further resource. In addition, the Company completed Cerillion 21.1 in the period. This is the latest version of its Enterprise OSS/BSS suite for fixed, mobile, cable and multi-service operators, and will be released this month. The new release provides customers with enhanced B2B functionality, with a particular focus on lead and opportunity management.

Β 

Cerillion's sales pipeline remains strong, and prospects for the remainder of the financial year are very positive.

Β 

Notice of results

Β 

The Board intends to announce interim results for the six months to 31 March 2021 on 17 May 2021, when the Company will provide a further update on current trading.Β 

Β 

Louis Hall, Chief Executive of Cerillion, commented:

Β 

"The business has performed very strongly over the first half, and new orders in the period have equalled total new orders for the whole of the last financial year. Our last contract win represented another major milestone for us, and reflects growing market recognition of the quality of our solution and services.

Β 

"We have a strong pipeline of potential new business and remain well-positioned for continuing growth this financial year and next."

Β 

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

Β 

Β 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Oliver Gilchrist, CFO

Β 

Β 

Β 

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Euan Brown, William Hall

Β 

Β 

Β 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

Β 

Β 

Β 

Β 

About Cerillion

www.cerillion.com

Β 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 90 customer installations across over 40 countries.

Β 

Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDZGMDDVNGMZM
Date   Source Headline
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.